Apply on Employer Site

Parker Institute for Cancer Immunotherapy · 6 days ago

VP, Corporate Development & Strategic Partnerships

San Francisco, CA

Full-time

Onsite

Director/Executive

$349K/yr - $374K/yr

10+ years exp

The Parker Institute for Cancer Immunotherapy (PICI) is a nonprofit organization focused on advancing cancer treatment through innovative immune therapies. They are seeking a Vice President of Corporate Development and Strategic Partnerships to drive collaboration with the biopharmaceutical industry and establish sustainable financial strategies for the organization. This role involves managing partnerships, securing funding, and overseeing the commercialization of PICI's scientific advancements.

Health CarePersonal HealthTherapeutics

No H1B

Responsibilities

Driving Commercial Growth and Strategic Alliances

Industry Partnership Building & Network Positioning:

Strategic Cultivation: Systematically identify, rigorously vet, and proactively manage executive-level professional relationships with Business Development (BD), Mergers & Acquisitions (M&A), and Research & Development (R&D) leaders within the world's leading biopharmaceutical and biotechnology organizations

Market Positioning: The central objective is to firmly establish the PICI Network—comprising top academic centers, proprietary data, and clinical trial capabilities—as the preeminent and reliable source of de-risked innovation in cancer immunotherapy

Performance Metric: A core, measurable deliverable is the development and management of a formalized pipeline of a minimum of twenty active, high-potential biopharma engagement opportunities within the initial year of tenure

Revenue Generation & Innovative Funding Models:

Securing Substantial Sponsorships: Lead the effort to secure significant financial sponsorships, strategic research agreements, and master collaboration agreements with industry partners

Impact Investing & Venture Philanthropy: Investigate, structure, and execute innovative funding structures that move beyond traditional grants, such as impact investments, venture philanthropy funds, and programmatic royalty-bearing deals. The goal is to strategically align substantial corporate R&D budgets and institutional investment capital with PICI’s mission and operational needs

Innovation Scouting & Venture Liaison:

Market Intermediation: Act as the critical interface between the external market (biopharma, venture capital, private equity) and PICI’s internal Venture and Business Development teams

Asset Monetization: Proactively identify, engage, and manage corporate partners and established venture capital firms with a specific interest in the investment, licensing, or outright acquisition of intellectual property and assets originating from PICI-incubated companies, research programs, or Network discoveries. This includes coordinating due diligence and market scoping activities

Network Commercialization & Asset Packaging:

Strategic Product Development: Collaborate extensively with the PICI Leadership Team, Scientific Leadership, and Legal Counsel to strategically analyze, package, and structure Network assets into commercially attractive, formalized partnership offerings for external industry engagement

Asset Classes: These partnership offerings include, but are not limited to: unique de-identified patient data sharing protocols, highly standardized multi-center clinical trial execution capabilities (Phase I/II), access to proprietary platforms, and distinct, high-potential intellectual property portfolios

Deal Structuring & Execution:

Negotiation & Finalization: Partner closely with the COAO and internal/external legal department to meticulously draft, negotiate, and finalize a comprehensive array of complex agreements

Document Scope: The scope of agreement encompasses, but is not limited to: Master Partnership Agreements, comprehensive Sponsorship Contracts, Licensing Agreements (in/out-licensing), Co-development Partnerships, Exclusive Option Agreements, and detailed Letters of Intent (LOIs) and Term Sheets

Qualification

Corporate DevelopmentBusiness DevelopmentAlliance ManagementInvestment BankingOncology ExpertiseImmunology ExpertiseFinancial TransactionsStakeholder ManagementNegotiation SkillsStrategic CommunicationScientific LiteracyLeadership Skills

Required

A mandatory minimum of ten (10) years of progressive, senior-level experience in Corporate Development, Business Development, Alliance Management, or Investment Banking specifically within the biotechnology, pharmaceutical, or venture-backed life sciences sectors is required

A Bachelor's degree from an accredited institution is required

The candidate must provide clear evidence of a proven capacity to successfully commercialize intellectual property, proprietary assets, or complex strategic collaborations derived from academic scientific networks, research consortia, or highly matrixed organizations

A comprehensive and profound understanding of the entire drug discovery and development lifecycle, from target identification through clinical development and commercial launch, is essential

Specific, deep domain expertise within the therapeutic areas of Oncology and Immunology is mandatory

A documented history of successfully negotiating and executing high-value transactions—specifically those valued in the six- and seven-figure range (USD) or higher—is a mandatory requirement for this executive role

The role demands highly effective Stakeholder Management skills across diverse and powerful constituencies, including leading academic principal investigators, philanthropic donors, scientific leaders, and industry executives

This must be coupled with a capacity for mission-aligned, strategic communication that can articulate complex science into clear commercial value propositions

Willingness to travel domestically and internationally as required to successfully execute the event portfolio

Must be authorized to work in the United States; we do not sponsor work visas

Preferred

An advanced degree is highly preferred, including but not limited to an MBA, a Master of Science (MS) in a relevant scientific discipline, or a Juris Doctor (JD), or equivalent demonstrable experience in a relevant technical or commercial field

Local candidates preferred